These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21436155)

  • 1. Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics.
    Obeid S; Printsevskaya SS; Olsufyeva EN; Dallmeier K; Durantel D; Zoulim F; Preobrazhenskaya MN; Neyts J; Paeshuyse J
    J Antimicrob Chemother; 2011 Jun; 66(6):1287-94. PubMed ID: 21436155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.
    Gal-Tanamy M; Zemel R; Bachmatov L; Jangra RK; Shapira A; Villanueva RA; Yi M; Lemon SM; Benhar I; Tur-Kaspa R
    Antiviral Res; 2010 Oct; 88(1):95-106. PubMed ID: 20705106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro.
    Jardim AC; Igloi Z; Shimizu JF; Santos VA; Felippe LG; Mazzeu BF; Amako Y; Furlan M; Harris M; Rahal P
    Antiviral Res; 2015 Mar; 115():39-47. PubMed ID: 25557602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virus.
    Wichroski MJ; Fang J; Eggers BJ; Rose RE; Mazzucco CE; Pokornowski KA; Baldick CJ; Anthony MN; Dowling CJ; Barber LE; Leet JE; Beno BR; Gerritz SW; Agler ML; Cockett MI; Tenney DJ
    PLoS One; 2012; 7(8):e42609. PubMed ID: 22880053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.
    Hirano J; Okamoto T; Sugiyama Y; Suzuki T; Kusakabe S; Tokunaga M; Fukuhara T; Sasai M; Tougan T; Matsunaga Y; Yamashita K; Sakai Y; Yamamoto M; Horii T; Standley DM; Moriishi K; Moriya K; Koike K; Matsuura Y
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):E10782-E10791. PubMed ID: 29187532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture.
    Silberstein E; Taylor DR
    Int J Biomed Sci; 2008 Jun; 4(2):82-8. PubMed ID: 23675072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycopeptides as Potential Interventions for COVID-19.
    Demsie DG; Gebre AK; Yimer EM; Alema NM; Araya EM; Bantie AT; Allene MD; Gebremedhin H; Yehualaw A; Tafere C; Tadese HT; Amare B; Weldekidan E; Gebrie D
    Biologics; 2020; 14():107-114. PubMed ID: 33116397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Therapeutic Options Under Investigation.
    Kaddoura M; AlIbrahim M; Hijazi G; Soudani N; Audi A; Alkalamouni H; Haddad S; Eid A; Zaraket H
    Front Pharmacol; 2020; 11():1196. PubMed ID: 32848795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity.
    Szűcs Z; Naesens L; Stevaert A; Ostorházi E; Batta G; Herczegh P; Borbás A
    Pharmaceuticals (Basel); 2020 Jun; 13(7):. PubMed ID: 32610683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophobic Derivatives of Glycopeptide Antibiotics as Inhibitors of Protein Kinases.
    Cozza G; Fortuna M; Meggio F; Sarno S; Kubbutat MHG; Totzke F; Schaechtele C; Pinna LA; Olsufyeva EN; Preobrazhenskaya MN
    Biochemistry (Mosc); 2018 Oct; 83(10):1222-1230. PubMed ID: 30472959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.
    Szűcs Z; Kelemen V; Le Thai S; Csávás M; Rőth E; Batta G; Stevaert A; Vanderlinden E; Naesens L; Herczegh P; Borbás A
    Eur J Med Chem; 2018 Sep; 157():1017-1030. PubMed ID: 30170320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fighting viruses with antibiotics: an overlooked path.
    Colson P; Raoult D
    Int J Antimicrob Agents; 2016 Oct; 48(4):349-52. PubMed ID: 27546219
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).
    Zhou N; Pan T; Zhang J; Li Q; Zhang X; Bai C; Huang F; Peng T; Zhang J; Liu C; Tao L; Zhang H
    J Biol Chem; 2016 Apr; 291(17):9218-32. PubMed ID: 26953343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teicoplanin inhibits Ebola pseudovirus infection in cell culture.
    Wang Y; Cui R; Li G; Gao Q; Yuan S; Altmeyer R; Zou G
    Antiviral Res; 2016 Jan; 125():1-7. PubMed ID: 26585243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.
    Daep CA; Muñoz-Jordán JL; Eugenin EA
    J Neurovirol; 2014 Dec; 20(6):539-60. PubMed ID: 25287260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication.
    Obeid S; Alen J; Nguyen VH; Pham VC; Meuleman P; Pannecouque C; Le TN; Neyts J; Dehaen W; Paeshuyse J
    PLoS One; 2013; 8(12):e81783. PubMed ID: 24349127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin.
    Vanderlinden E; Vanstreels E; Boons E; ter Veer W; Huckriede A; Daelemans D; Van Lommel A; Rőth E; Sztaricskai F; Herczegh P; Naesens L
    J Virol; 2012 Sep; 86(17):9416-31. PubMed ID: 22740402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teicoplanin therapy leading to a significant decrease in viral load in a patient with chronic hepatitis C.
    Maieron A; Kerschner H
    J Antimicrob Chemother; 2012 Oct; 67(10):2537-8. PubMed ID: 22687891
    [No Abstract]   [Full Text] [Related]  

  • 19. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.
    De Burghgraeve T; Kaptein SJ; Ayala-Nunez NV; Mondotte JA; Pastorino B; Printsevskaya SS; de Lamballerie X; Jacobs M; Preobrazhenskaya M; Gamarnik AV; Smit JM; Neyts J
    PLoS One; 2012; 7(5):e37244. PubMed ID: 22624001
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.